Zimbabwe has declined a substantial US health deal valued at $367m (272 million pounds) over five years due to Washington's insistence on sensitive information.
This move was revealed following a internal memorandum from December was leaked, which showed President Emmerson Mnangagwa believed the deal was "unbalanced".
An official spokesperson has since explained that the US was requesting biological samples for scientific study and commercial purposes while was not willing to guarantee the benefits from future treatments.
"We must now begin the challenging and unfortunate process of winding down our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy noted the US had donated over $1.9bn in health funding to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has urged continued negotiations to secure a agreement acceptable to both sides so the country's vital HIV treatment initiative can be sustained.
Broader Implications
This rejection comes after a comparable case in Kenya, where a high court halted a related health funding agreement following legal challenges were raised about the security of citizens' health data.
After returning to the presidency recently, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).
USAID had administered assistance for the US government, but Trump claimed its expenditure was "inefficient" and his administration was pursuing government-to-government deals to enhance transparency and responsibility.
According to statements, Sixteen nations in Africa have so far agreed to these new agreements, constituting over $18.3bn in committed funds.
Specifics of the Rejected Agreement
The money for Zimbabwe was intended to funded "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this cooperation could have provided extraordinary advantages for Zimbabwean communities, especially the 1.2 million men, women and children presently on antiretroviral therapy via US-supported programmes," the Ambassador added.
However, official spokesman Nick Mangwana argued the arrangement was "unfair".
"The proposal required Zimbabwe to provide its biological resources and data for a long time, with no equivalent promise of access to any medical innovations – like new medicines or tests – that could result from that provided information," Mangwana explained.
"Effectively, our nation would supply the raw materials for scientific discovery without any assurance that the final treatments would be accessible to our population if a future disease outbreak emerge."
Sovereignty and International Frameworks
Mangwana further said that the American exit from the global health body and its push of one-on-one health agreements were disrupting systems previously set up through the global organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing system designed to manage potential global health emergencies.
"This framework is intended to ensure that when a country provides its samples, the resulting advantages – including vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the resources to develop them."
The government's concerns over the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We welcome ongoing discussions with our American counterparts on how subsequent collaboration could be arranged in a way that respects the independence and dignity of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the official position, but suggested that negotiations must proceed considering a large portion of the country's HIV programmes were funded by international support.
"In cases where specific concerns arise, such as those relating to information security or agreement terms, these can frequently be resolved through technical clarification and mutually agreed protections," the group commented.
The situation underscores the complex challenges between receiving vital foreign assistance and safeguarding a country's data in an increasingly data-driven world.